enGene Therapeutics ENGN
NASDAQ ENGN
$1.58 -0.05 (-3.07%)
At close: Oct 22, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Change in Other Operating Liabilities (2024 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Change in Other Operating Liabilities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 2.69 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -112.00 Mn
10 enGene Therapeutics 105.88 Mn -888.59 Mn - -294,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -294,000.00
Apr 30, 2026 -282,000.00
Jan 31, 2026 39,000.00
Oct 31, 2025 231,000.00
Jul 31, 2025 131,000.00
Apr 30, 2025 80,000.00
Jan 31, 2025 -168,000.00
Oct 31, 2024 -43,000.00
Jul 31, 2024 -41,000.00
Apr 30, 2024 -2,000.00
Jan 31, 2024 37,000.00
API Access

enGene Therapeutics Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=ENGN&period=max&api_key=YOUR_API_KEY